AI-Driven Discovery of Brain-Penetrant Galectin-3 Inhibitors for Alzheimer’s Disease Therapy.
AI identifies FJMU1887, a Gal-3 inhibitor, enhancing cognition and reducing neuroinflammation in Alzheimer’s models. ๐ง ๐
June 23, 2025
Follow us
latest articles
Discover the newest research about AI innovations in ๐งช Drug Discovery.
AI Identifies Non-Cancer Drugs That May Effectively Target Cancer Cells
AI identifies non-cancer drugs that may effectively target cancer cells. Promising combinations show potential for future research. ๐งฌ๐
June 23, 2025
Applications of artificial intelligence in drug discovery for neurological diseases.
AI revolutionizes drug discovery for neurological diseases, enhancing molecule identification and treatment potential. ๐ค๐
June 19, 2025
Artificial intelligence applications in rare and intractable diseases: Advances, challenges, and future directions.
AI transforms rare disease diagnosis and treatment, addressing 3.5%-5.9% of global cases. Key advancements and challenges discussed. ๐ค๐
June 10, 2025
Newcastle Hospitals Develops Data Platform for Enhanced Medical Research
Newcastle Hospitals is enhancing medical research with a new data platform. This aims to improve patient outcomes and support innovation. ๐๐ฅ
June 6, 2025
Invitation for Submissions: AI in Biomedical Engineering
AI in Biomedical Engineering: Call for Papers ๐๐ค
Submissions welcome for research on AI’s role in medical advancements. Explore innovative applications and insights.
June 4, 2025
Enhancing search strategies for systematic reviews on drug Harms: An evaluation of the utility of ChatGPT in error detection and keyword generation.
ChatGPT enhances drug harm reviews: 49% keyword recreation, 0.17 Jaccard similarity. Effective error detection tool! ๐๐
May 30, 2025
National Taiwan University Hospital Launches AI for Pancreatic Cancer Imaging
National Taiwan University Hospital introduces AI for pancreatic cancer imaging, enhancing early detection and diagnostic accuracy. ๐ฅ๐ป
May 28, 2025
Generative AI’s Role in Advancing Drug Development
Generative AI is enhancing drug development efficiency. The DiffSMol model shows a 61.4% success rate in creating promising drug candidates. ๐โจ
May 27, 2025
Persist AI Raises $12 Million in Series A Funding and Launches Cloud Lab
Persist AI secures $12 million in funding and launches Cloud Lab, enhancing drug formulation efficiency with AI and robotics. ๐ค๐
May 22, 2025